Latest news
Clarity Pharmaceuticals (ASX:CU6): Radiopharmaceutical Innovation Under Spotlight After Share Price Gain - KalkineKalkine · Thu, 06 Aug 2026 02:40:00 GMTState Street Corporation Declares 5.02% Stake in Clarity Pharmaceuticals (ASX:CU6) - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 08:27:21 GMTClarity Pharmaceuticals Receives Substantial Holder Notice from State Street Corporation - KalkineKalkine · Wed, 05 Aug 2026 08:27:21 GMTClarity Pharmaceuticals Grants 9.37 Million Unquoted Options Under Employee Incentive Plan - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 06:58:29 GMTClarity Pharmaceuticals Issues 9.37 Million Unquoted Options Under Employee Incentive Scheme - KalkineKalkine · Wed, 05 Aug 2026 06:58:29 GMTClarity Pharmaceuticals (ASX:CU6) Share Price Jumps, CU6 Advances Cancer Therapy Trial Results - KalkineKalkine · Wed, 05 Aug 2026 02:08:00 GMTClarity Pharmaceuticals Reports Two New Complete Responses in SECuRE Trial 8 GBq Dose Cohorts - KalkineKalkine · Wed, 05 Aug 2026 00:55:33 GMTWhy Clarity Pharmaceuticals Ltd (ASX:CU6) Is Gaining Attention in the Biotech Space - KalkineKalkine · Tue, 04 Aug 2026 12:07:00 GMT